The recent use of calcein (CA) as a fluorescent probe for cellular iron has been shown to reflect the nutritional status of iron in mammalian cells (Breuer, W., Epsztejn, S., and Cabantchik, Z. I. (1995) J. Biol. Chem. 270, 24209 -24215). CA was claimed to be a chemosensor for iron(II), to measure the labile iron pool and the concentration of cellular free iron(II). We first study here the thermodynamic and kinetic properties of iron binding by CA. Chelation of a first iron(III) involves one aminodiacetic arm and a phenol.
The complexation of FeIII by new tetradentate and pentadentate aminocarboxylate chelators, designed to protect cells against iron‐catalysed oxidative damage, was investigated. Ferric iron complexes of N,N′‐bis(3,4,5‐trimethoxybenzyl)ethylenediamine‐N,N′‐diacetic acid (L1), N,N′‐dibenzylethylenediamine‐N,N′‐diacetic acid (L2) and [N‐(2‐hydroxybenzyl)‐N′‐benzylethylenediamine‐N,N′‐diacetic acid] (L3) have been characterized in aqueous solution by potentiometric, UV/Vis spectrophotometric and cyclic voltammetric measurements. The parent ligand, ethylenediamine‐N,N′‐diacetic acid (L4), has also been studied. As expected, the presence of a hard phenolate donor group in L3 significantly enhances the affinity for iron while decreasing the potential of the FeIII/FeII redox couple compared to L1 or L2. Kinetics studies have provided the kinetic rate constants related to the formation and the dissociation of the ferric complex with L3. The results reveal a fast FeIII uptake, which is a favorable feature for a biological use of this type of ligand. Overall, these results demonstrate the pertinence of the use of such ligands to protect biological tissues against oxidative stress.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.